Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) Overview
Pro stress-test →SPIMACO is the #1 private pharmaceutical company in Saudi Arabia, offering a diverse portfolio of over 400 products with operations across 7 state-of-the-art manufacturing facilities in 4 countries and an annual production capacity exceeding 2.3 billion units. The company operates in 21 strategic markets across the Middle East and North Africa, positioning itself as a regional leader in generic and biosimilar pharmaceuticals.
Strategic Profile
Pro stress-test →SPIMACO is positioned as Saudi Arabia's leading generics and biosimilar pharmaceutical manufacturer, commanding a robust 7.4% private sector market share and holding a prominent position in the Middle East. The company has accelerated efforts towards realizing its strategic ambition of becoming the national champion for the Kingdom's pharmaceutical industry and the leading pharmaceutical company in the MENA region, leveraging favorable market dynamics and a growing aging patient base.
Competitive Landscape
Pro stress-test →SPIMACO is positioned as Saudi Arabia's leading generics and biosimilar pharmaceutical manufacturer, competing primarily against international pharma firms and regional generic manufacturers in the MENA pharmaceutical market. The company differentiates through vertically integrated manufacturing, broad product portfolio, and regional distribution network.
Industry Context
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) operates in Generic and biosimilar pharmaceuticals.
Key facts
Founded: 1986 · Headquarters: Riyadh, Saudi Arabia · Employees: N/A · Revenue: $416.5M · Market cap: N/A